| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Novel Method for Deriving Adverse Event Prevalence in Randomized Controlled Trials: Potential for Improved Understanding of Benefit-Risk Ratio and Application to Drug Labels
|
Piacentino, Daria
|
|
|
41 |
1 |
p. 152-169
|
artikel
|
| 2 |
A Patient Charter for Chronic Urticaria
|
Maurer, Marcus
|
|
|
41 |
1 |
p. 14-33
|
artikel
|
| 3 |
A Retrospective Observational Real-Word Analysis of the Adherence, Healthcare Resource Consumption and Costs in Patients Treated with Bisoprolol/Perindopril as Single-Pill or Free Combination
|
Masi, Stefano
|
|
|
41 |
1 |
p. 182-197
|
artikel
|
| 4 |
A Risk-Based Approach for Safety Case Follow-up of Adverse Event Reports in Pharmacovigilance
|
Vemula, Ganesh Kumar
|
|
|
41 |
1 |
p. 82-91
|
artikel
|
| 5 |
Assessing the Fiscal Burden of Obesity in Canada by Applying a Public Economic Framework
|
Kotsopoulos, Nikos
|
|
|
41 |
1 |
p. 379-390
|
artikel
|
| 6 |
Association of Patient Satisfaction with Cataract Grading in Five Types of Multifocal IOLs
|
Niazi, Sana
|
|
|
41 |
1 |
p. 231-245
|
artikel
|
| 7 |
Bowel Urgency in Patients with Ulcerative Colitis and Crohn’s Disease: A Cross-Sectional Real-World Survey in Japan
|
Wang, Chaochen
|
|
|
41 |
1 |
p. 431-450
|
artikel
|
| 8 |
Correction to: VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease
|
Mezalek, Zoubida Tazi
|
|
|
41 |
1 |
p. 464-465
|
artikel
|
| 9 |
Dosing Patterns of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab in the United States: A Retrospective Claims-Based Analysis
|
Cheng, Wendy Y.
|
|
|
41 |
1 |
p. 413-430
|
artikel
|
| 10 |
Effect of Remifentanil on the Tpeak-Tend Interval During Electroconvulsive Therapy
|
Eda, Kozue
|
|
|
41 |
1 |
p. 262-270
|
artikel
|
| 11 |
Efficacy and Safety of Different Doses of Rivaroxaban and Risk Factors for Bleeding in Elderly Patients with Venous Thromboembolism: A Real-World, Multicenter, Observational, Cohort Study
|
Lu, Kepeng
|
|
|
41 |
1 |
p. 391-412
|
artikel
|
| 12 |
Health Economic Assessments of Hyaluronic Acid Treatments for Knee Osteoarthritis: A Systematic Review
|
Ranawat, Anil
|
|
|
41 |
1 |
p. 65-81
|
artikel
|
| 13 |
Human Dose and Pharmacokinetic Predictions for Biologics at Boehringer Ingelheim: A Retrospective Analysis
|
Grempler, Rolf
|
|
|
41 |
1 |
p. 364-378
|
artikel
|
| 14 |
LOGAN-CV: A Prospective Study of a Multifaceted Intervention Targeting United States Clinicians to Improve Guideline-Based Management of Lipid-Lowering Therapy
|
McKoy, J. Nikki
|
|
|
41 |
1 |
p. 451-463
|
artikel
|
| 15 |
One-Year Consistent Safety, Utilization, and Efficacy Assessment of Remote Electrical Neuromodulation (REN) for Migraine Treatment
|
Synowiec, Andrea
|
|
|
41 |
1 |
p. 170-181
|
artikel
|
| 16 |
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group
|
Fazio, Nicola
|
|
|
41 |
1 |
p. 113-129
|
artikel
|
| 17 |
Optimizing FSH Concentration Modulation in the Short-Acting GnRH-a Long Protocol for IVF/ICSI: A Retrospective Study
|
Hu, Lingmin
|
|
|
41 |
1 |
p. 215-230
|
artikel
|
| 18 |
Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH)
|
McLaughlin, Vallerie
|
|
|
41 |
1 |
p. 130-151
|
artikel
|
| 19 |
Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium–Glucose Cotransporter 2 Inhibitors
|
Verma, Subodh
|
|
|
41 |
1 |
p. 92-112
|
artikel
|
| 20 |
Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure
|
Berezina, Tetiana A.
|
|
|
41 |
1 |
p. 292-314
|
artikel
|
| 21 |
Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study
|
Schmalzing, Marc
|
|
|
41 |
1 |
p. 315-330
|
artikel
|
| 22 |
Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe
|
Jin, Ran
|
|
|
41 |
1 |
p. 331-348
|
artikel
|
| 23 |
Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study
|
Chandra Shekhar, Harshith
|
|
|
41 |
1 |
p. 246-261
|
artikel
|
| 24 |
The Burden Patients with Myasthenia Gravis Experience in Terms of Breathing, Fatigue, Sleep, Mental Health, Discomfort and Usual Activities in Comparison to the General Population
|
Dewilde, S.
|
|
|
41 |
1 |
p. 271-291
|
artikel
|
| 25 |
The Impact of Biosimilar Use on Total Cost of Care and Provider Financial Performance in the Medicare Oncology Care Model: A Population-Based Simulation Study
|
Yang, Jingyan
|
|
|
41 |
1 |
p. 349-363
|
artikel
|
| 26 |
Treatment-Resistant Depression in Real-World Clinical Practice: A Systematic Literature Review of Data from 2012 to 2022
|
Oliveira-Maia, Albino J.
|
|
|
41 |
1 |
p. 34-64
|
artikel
|
| 27 |
Unmet Needs in the Acute Treatment of Migraine
|
Bentivegna, Enrico
|
|
|
41 |
1 |
p. 1-13
|
artikel
|
| 28 |
Vosoritide Therapy in Children with Achondroplasia: Early Experience and Practical Considerations for Clinical Practice
|
Semler, Oliver
|
|
|
41 |
1 |
p. 198-214
|
artikel
|
Tijdschrift beschrijving